Luminex ROA 2006-2018 | LMNX

Current and historical return on assets (ROA) values for Luminex (LMNX) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Luminex ROA for the three months ending December 31, 2018 was 4.18%.
Luminex ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-12-31 $0.02B $0.53B 3.51%
2018-09-30 $0.02B $0.52B 3.57%
2018-06-30 $0.03B $0.51B 6.87%
2018-03-31 $0.03B $0.50B 7.05%
2017-12-31 $0.03B $0.49B 6.40%
2017-09-30 $0.03B $0.48B 6.54%
2017-06-30 $0.02B $0.46B 3.34%
2017-03-31 $0.02B $0.45B 3.38%
2016-12-31 $0.02B $0.45B 3.47%
2016-09-30 $0.04B $0.44B 9.03%
2016-06-30 $0.04B $0.44B 10.14%
2016-03-31 $0.04B $0.40B 9.79%
2015-12-31 $0.04B $0.40B 9.56%
2015-09-30 $0.04B $0.38B 10.68%
2015-06-30 $0.04B $0.37B 11.02%
2015-03-31 $0.04B $0.36B 12.03%
2014-12-31 $0.04B $0.36B 12.17%
2014-09-30 $0.02B $0.33B 6.97%
2014-06-30 $0.02B $0.32B 5.55%
2014-03-31 $0.02B $0.31B 5.36%
2013-12-31 $0.01B $0.31B 2.38%
2013-09-30 $0.01B $0.29B 2.05%
2013-06-30 $0.01B $0.28B 2.42%
2013-03-31 $0.01B $0.29B 2.08%
2012-12-31 $0.01B $0.30B 4.56%
2012-09-30 $0.01B $0.28B 4.26%
2012-06-30 $0.01B $0.28B 4.27%
2012-03-31 $0.01B $0.28B 5.02%
2011-12-31 $0.01B $0.28B 5.08%
2011-09-30 $0.01B $0.28B 5.16%
2011-06-30 $0.01B $0.27B 4.14%
2011-03-31 $0.01B $0.27B 2.68%
2010-12-31 $0.01B $0.27B 1.95%
2010-09-30 $0.02B $0.26B 8.73%
2010-06-30 $0.02B $0.25B 9.08%
2010-03-31 $0.02B $0.25B 9.46%
2009-12-31 $0.02B $0.25B 7.56%
2009-09-30 $-0.00B $0.22B -0.46%
2009-06-30 $0.00B $0.22B 1.39%
2009-03-31 $0.00B $0.22B 0.47%
2008-12-31 $0.00B $0.22B 1.59%
2008-09-30 $0.01B $0.21B 7.24%
2008-06-30 $0.01B $0.20B 4.98%
2008-03-31 $-0.00B $0.12B -3.40%
2007-12-31 $-0.00B $0.12B -2.55%
2007-09-30 $-0.01B $0.11B -12.59%
2007-06-30 $-0.01B $0.11B -12.05%
2007-03-31 $0.00B $0.12B 1.28%
2006-12-31 $0.00B $0.07B 3.23%
2006-09-30 $0.00B $0.06B 0.00%
2006-06-30 $-0.00B $0.06B -1.74%
2006-03-31 $-0.00B $0.06B -1.79%
2005-12-31 $-0.00B $0.06B -3.65%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.071B $0.316B
Luminex Corporation is committed to applying its passion for innovation toward advancing healthcare and research worldwide. The Company is transforming global healthcare and life-science research through the development, manufacturing and marketing of proprietary instruments and assays utilizing xMAP open-architecture, multi-analyte platform and MultiCode real-time polymerase chain reaction (PCR) and multiplex PCR-based technologies, that deliver cost-effective and rapid results to clinicians and researchers. Luminex's technology is commercially available worldwide and in use in leading clinical laboratories as well as major pharmaceutical, diagnostic, biotechnology and life-science companies. The Company is meeting the needs of customers in markets as diverse as clinical diagnostics, pharmaceutical drug discovery, biomedical research including genomic and proteomic research, personalized medicine, bio-defense research and food safety.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $104.974B 23.66
Intuitive Surgical (ISRG) United States $64.396B 60.15
Edwards Lifesciences (EW) United States $37.346B 38.24
Fresenius Medical Care AG KGaA (FMS) Germany $24.137B 16.52
IDEXX Laboratories (IDXX) United States $18.595B 50.63
ABIOMED (ABMD) United States $15.024B 99.18
Teleflex (TFX) United States $13.940B 30.57
Hologic (HOLX) United States $13.875B 20.98
DexCom (DXCM) United States $13.590B 520.69
Varian Medical Systems (VAR) United States $12.400B 30.98
STERIS (STE) United Kingdom $10.436B 26.82
Masimo (MASI) United States $7.100B 44.21
Penumbra (PEN) United States $5.383B 304.57
Integra LifeSciences Holdings (IART) United States $4.774B 23.15
LivaNova (LIVN) United Kingdom $4.666B 28.52
Globus Medical (GMED) United States $4.605B 27.95
Tandem Diabetes Care (TNDM) United States $4.222B 0.00
Wright Medical Group (WMGI) Netherlands $4.069B 0.00
Cantel Medical (CMD) United States $2.836B 28.20
Integer Holdings (ITGR) United States $2.786B 22.73
Glaukos (GKOS) United States $2.612B 0.00
Inogen (INGN) United States $2.075B 41.36
AVANOS MEDICAL, INC (AVNS) United States $2.041B 22.17
OPKO Health (OPK) United States $1.545B 0.00
Nevro (NVRO) United States $1.327B 0.00
Tactile Systems Technology (TCMD) United States $1.189B 225.68
CryoLife (CRY) United States $1.120B 121.04
Pacific Biosciences Of California (PACB) United States $1.111B 0.00
Accelerate Diagnostics (AXDX) United States $1.079B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $1.077B 29.28
Intersect ENT (XENT) United States $1.047B 0.00
Natus Medical (BABY) United States $0.928B 19.34
Mesa Laboratories (MLAB) United States $0.913B 37.33
Veracyte (VCYT) United States $0.890B 0.00
AxoGen (AXGN) United States $0.812B 0.00
AngioDynamics (ANGO) United States $0.808B 26.20
ViewRay (VRAY) United States $0.782B 0.00
OrthoPediatrics (KIDS) United States $0.637B 0.00
Quotient (QTNT) Switzerland $0.622B 0.00
Fluidigm (FLDM) United States $0.537B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.480B 50.56
Si-Bone (SIBN) United States $0.452B 0.00
GenMark Diagnostics (GNMK) United States $0.397B 0.00
Accuray (ARAY) United States $0.392B 0.00
Pulse Biosciences (PLSE) United States $0.375B 0.00
RTI Surgical (RTIX) United States $0.374B 54.54
Neuronetics (STIM) United States $0.291B 0.00
IRadimed (IRMD) United States $0.289B 61.14
SeaSpine Holdings (SPNE) United States $0.279B 0.00
Sientra (SIEN) United States $0.258B 0.00
Nuvectra (NVTR) United States $0.221B 0.00
Helius Medical Technologies (HSDT) United States $0.167B 0.00
Ekso Bionics Holdings (EKSO) United States $0.159B 0.00
Sensus Healthcare (SRTS) United States $0.148B 0.00
Alphatec Holdings (ATEC) United States $0.126B 0.00
ConforMIS (CFMS) United States $0.121B 0.00
Biosig Technologies (BSGM) United States $0.120B 0.00
T2 Biosystems (TTOO) United States $0.119B 0.00
Second Sight Medical Products (EYES) United States $0.101B 0.00
Vermillion (VRML) United States $0.096B 0.00
SOLITON INC (SOLY) $0.095B 0.00
EDAP TMS (EDAP) France $0.085B 0.00
Apollo Endosurgery (APEN) United States $0.073B 0.00
Titan Medical (TMDI) Canada $0.072B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.068B 0.00
Ra Medical Systems (RMED) United States $0.056B 0.00
OBALON THERPTCS (OBLN) United States $0.042B 0.00
Avinger (AVGR) United States $0.038B 0.00
Microbot Medical (MBOT) United States $0.037B 0.00
Restoration Robotics (HAIR) United States $0.037B 0.00
Viveve Medical (VIVE) United States $0.029B 0.00
PAVmed (PAVM) United States $0.029B 0.00
Lianluo Smart (LLIT) China $0.025B 0.00
DarioHealth (DRIO) Israel $0.024B 0.00
Atossa Genetics (ATOS) United States $0.020B 0.00
Bioanalytical Systems (BASI) United States $0.020B 63.33
Dynatronics (DYNT) United States $0.018B 0.00
Presbia (LENS) Ireland $0.018B 0.00
ReWalk Robotics (RWLK) Israel $0.018B 0.00
ENDRA Life Sciences (NDRA) United States $0.016B 0.00
Nanovibronix (NAOV) United States $0.015B 0.00
Neovasc (NVCN) Canada $0.013B 0.00
Allied Healthcare Products (AHPI) United States $0.007B 0.00
Cesca Therapeutics (KOOL) United States $0.007B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.005B 0.00
Sunshine Heart Inc (CHFS) United States $0.002B 0.00
Check-Cap (CHEK) Israel $0.000B 0.00